The European Bank for Reconstruction and Development has agreed to invest 6 million euros to support European Metals Holdings' (ASX:EMH) development of the Cinovec lithium project in the Czech Republic. Executive Chairman Keith Coughlan discusses the significance of the placement and the momentum behind lithium in Europe.
Copyright 2023 – Finance News Network
16 Aug 2023 - Mark Leong - Executive Chairman - Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
10 Oct 2023 - Paul Lock - Chairman & Managing Director - Pan Asia Metals (PAM) is a minerals exploration and development company with tungsten and lithium projects located in southern Thailand.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
24 Jun 2020 - Acorn Capital, portfolio manager Rick Squire talks about the energy and resource sectors, some of the funds best ideas and outlook for commodities and energy prices as the world emerges from OCIVD-19 lockdown.
02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
08 Jun 2021 - MLC Asset Management Senior Economist Bob Cunneen discusses factors behind gains in the global economy and the Australian market over May.
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
18 Aug 2022 - eCargo Holdings Limited (ASX:ECG) Group CEO Lawrence Lun discusses the rationale for the sale of digital consultancy company Amblique, how the proceeds will be used, and the roadmap for the coming months.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.